Technology-based assessment of motor and nonmotor phenomena in Parkinson disease

References

• Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Prim 2017;3:17013
   PubMed Web of Science ®Google Scholar
• Goetz CG, Stebbins GT, Wolff D, et al. Testing objective measures of motor impairment in early Parkinson’s disease: feasibility study of an at-home testing device. Mov Disord. 2009;24:551–556
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Chaudhuri KR, Rojo-Abuin JM, et al. Assessing the non-motor symptoms of Parkinson’s disease: MDS-UPDRS and NMS Scale. Eur J Neurol. 2015;22:37–43
   PubMed Web of Science ®Google Scholar
• Roy SH, Cole BT, Gilmore LD, et al. High-resolution tracking of motor disorders in Parkinson’s disease during unconstrained activity. Mov Disord 2013;28:1080–1087
   PubMed Web of Science ®Google Scholar
• Zhan A, Mohan S, Tarolli C, et al. Using smartphones and machine learning to quantify parkinson disease severity. JAMA Neurol 2018; 75:876–880
   PubMed Web of Science ®Google Scholar
• Aghanavesi S, Nyholm D, Senek M, et al. A smartphone-based system to quantify dexterity in Parkinson’s disease patients. Informatics Med Unlocked. 2017;9:11–17
   Google Scholar
• Kostikis N, Hristu-Varsakelis D, Arnaoutoglou M, et al. A smartphone-based tool for assessing Parkinsonian hand tremor. IEEE J Biomed Heal Informatics. 2015;19:1835–1842
   PubMed Web of Science ®Google Scholar
• Haubenberger D, Kalowitz D, Nahab FB, et al. Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor. Mov Disord 2011;26:2073–2080
   PubMed Web of Science ®Google Scholar
• Naismith SL, Rogers NL, Mackenzie J, et al. The relationship between actigraphically defined sleep disturbance and REM sleep behavior disorder in Parkinson’s disease. Clin Neurol Neurosurg. 2010;112:420–423
   PubMed Web of Science ®Google Scholar
• Vichayanrat E, Low DA, Iodice V, et al. Twenty-four-hour ambulatory blood pressure and heart rate profiles in diagnosing orthostatic hypotension in Parkinson’s disease and multiple system atrophy. Eur J Neurol 2017;24:90–97
   PubMed Web of Science ®Google Scholar
• Maetzler W, Domingos J, Srulijes K, et al. Quantitative wearable sensors for objective assessment of Parkinson’s disease. Mov Disord 2013;28:1628–1637
   PubMed Web of Science ®Google Scholar
• Stone AA, Shiffman S, Schwartz JE, et al. Patient compliance with paper and electronic diaries. Control Clin Trials 2003;24:182–199
   PubMedGoogle Scholar
• Hobart JC, Cano SJ, Zajicek JP, et al. Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. Lancet Neurology 2007;6;1094–1105
   PubMed Web of Science ®Google Scholar
• Broderick JE Electronic diaries: appraisal and current status. Pharmaceut Med. 2008;22:69–74
   PubMedGoogle Scholar
• Food and Drug Administration 2009. Patient-reported outcome measures: use in medicinal product development to support labelling claims. Washington, DC: Office of Communications, Division of Drug Information Center for Drug Evaluation and Research Food and Drug Administration
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al., PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269
   PubMed Web of Science ®Google Scholar
• NHLBI, Research Triangle Institute International. National heart, lung, and blood institute quality appraisal tools [online]. [cited 2018 Jun 14]. Available from: https://www.nhlbi.nih.gov/health-topics/studyquality-assessment-tools
   Google Scholar
• Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of InterventionsVersion 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. https://training.cochrane.org/handbook
   Google Scholar
• Kelly VE, Hyngstrom AS, Rundle MM, et al. Interaction of levodopa and cues on voluntary reaching in Parkinson’s disease. Mov Disord. 2002;17:38–44
   PubMed Web of Science ®Google Scholar
• Stolze H, Klebe S, Poepping M, et al. Effects of bilateral subthalamic nucleus stimulation on parkinsonian gait. Neurology. 2001;57:144–146
   PubMed Web of Science ®Google Scholar
• Johnson MT, Mendez A, Kipnis AN, et al. Acute effects of levodopa on wrist movement in Parkinson’s disease. Kinematics, volitional EMG modulation and reflex amplitude modulation. Brain. 1994;117:1409–1422
   PubMed Web of Science ®Google Scholar
• Merello M, Fantacone N, Balej J Kinematic study of whole body center of mass position during gait in Parkinson’s disease patients with and without festination. Mov Disord. 2010;25:747–754
   PubMed Web of Science ®Google Scholar
• Martin M, Shinberg M, Kuchibhatla M, et al. Gait initiation in community-dwelling adults with Parkinson disease: comparison with older and younger adults without the disease. Phys Ther. 2002;82:566–577
   PubMed Web of Science ®Google Scholar
• Chomiak T, Pereira FV, Meyer N, et al. A new quantitative method for evaluating freezing of gait and dual-attention task deficits in Parkinson’s disease. J Neural Transm (Vienna). 2015;122:1523–1531
   PubMed Web of Science ®Google Scholar
• Dillmann U, Holzhoffer C, Johann Y, et al. Principal component analysis of gait in Parkinson’s disease: relevance of gait velocity. Gait Posture. 2014;39:882–887
   PubMed Web of Science ®Google Scholar
• Rand MK, Lemay M, Squire LM, et al. Control of aperture closure initiation during reach-to-grasp movements under manipulations of visual feedback and trunk involvement in Parkinson’s disease. Exp Brain Res. 2010;201:509–525
   PubMed Web of Science ®Google Scholar
• Kim S, Horak FB, Carlson-Kuhta P, et al. Postural feedback scaling deficits in Parkinson’s disease. J Neurophysiol. 2009;102:2910–2920
   PubMed Web of Science ®Google Scholar
• Carpinella I, Crenna P, Calabrese E, et al. Locomotor function in the early stage of Parkinson’s disease. IEEE Trans Neural Syst Rehabil Eng. 2007;15:543–551
   PubMed Web of Science ®Google Scholar
• Conradsson D, Paquette C, Lökk J et al. Pre- and unplanned walking turns in Parkinson’s disease - effects of dopaminergic medication. Neuroscience. 2017;341:18–26
   PubMed Web of Science ®Google Scholar
• Barbe MT, Amarell M, Snijders AH, et al. Gait and upper limb variability in Parkinson’s disease patients with and without freezing of gait. J Neurol. 2014;261:330–342
   PubMed Web of Science ®Google Scholar
• Van Emmerik RE, Wagenaar RC, Winogrodzka A, et al. Identification of axial rigidity during locomotion in Parkinson disease. Arch Phys Med Rehabil.1999;80:186–191
   PubMed Web of Science ®Google Scholar
• McVey MA, Stylianou AP, Luchies CW, et al. Early biomechanical markers of postural instability in Parkinson’s disease. Gait Posture. 2009;30:538–542
   PubMed Web of Science ®Google Scholar
• Hong M, Perlmutter JS, Earhart GM A kinematic and electromyographic analysis of turning in people with Parkinson disease. Neurorehabil Neural Repair. 2009;23:166–176
   PubMed Web of Science ®Google Scholar
• Huxham F, Baker R, Morris ME, et al. Head and trunk rotation during walking turns in Parkinson’s disease. Mov Disord. 2008;23:1391–1397
   PubMed Web of Science ®Google Scholar
• Alice N, Fabienne C, Anne-Marie W, et al. Does freezing in Parkinson’s disease change limb coordination? A kinematic analysis. J Neurol. 2007;254:1268–1277
   PubMed Web of Science ®Google Scholar
• Hong M, Perlmutter JS, Earhart GM Podokinetic after-rotation in Parkinson disease. Brain Res. 2007;1128:99–106
   PubMed Web of Science ®Google Scholar
• Svehlík M, Zwick EB, Steinwender G, et al. Gait analysis in patients with Parkinson’s disease off dopaminergic therapy. Arch Phys Med Rehabil. 2009;90:1880–1886
   PubMed Web of Science ®Google Scholar
• Son M, Youm C, Cheon S, et al. Evaluation of the turning characteristics according to the severity of Parkinson disease during the timed up and go test. Aging Clin Exp Res. 2017;29:1191–1199
   PubMed Web of Science ®Google Scholar
• Fimbel E, Dubarry AS, Philibert M, et al. Event identification in movement recordings by means of qualitative patterns. Neuroinformatics. 2003;1:239–257
   PubMed Web of Science ®Google Scholar
• Cho C, Kunin M, Kudo K, et al. Frequency-velocity mismatch: a fundamental abnormality in parkinsonian gait. J Neurophysiol. 2010;103:147889
   Web of Science ®Google Scholar
• Ferrarin M, Lopiano L, Rizzone M, et al. Quantitative analysis of gait in Parkinson’s disease: a pilot study on the effects of bilateral sub thalamic stimulation. Gait Posture. 2002;16:135–148
   PubMed Web of Science ®Google Scholar
• Ferrarin M, Rizzone M, Bergamasco B, et al. Effects of bilateral subthalamic stimulation on gait kinematics and kinetics in Parkinson’s disease . Exp Brain Res. 2005;160:517–527
   PubMed Web of Science ®Google Scholar
• Johnsen EL, Sunde N, Mogensen PH et al. MRI verified STN stimulation site—gait improvement and clinical outcome. Eur J Neurol. 2010;17:746–753
   PubMed Web of Science ®Google Scholar
• Salarian A, Horak FB, Zampieri C, et al. iTUG, a sensitive and reliable measure of mobility. IEEE Trans Neural Syst Rehabil Eng. 2010;18:303–310
   PubMed Web of Science ®Google Scholar
• Parisi F, Ferrari G, Giuberti M, et al. Body-sensor-network-based kinematic characterization and comparative outlook of UPDRS scoring in leg agility, sit-to-stand, and gait tasks in Parkinson’s disease. IEEE J Biomed Health Inform. 2015;19:1777–1793
   PubMed Web of Science ®Google Scholar
• Zampieri C, Salarian A, Carlson-Kuhta P, et al. Assessing mobility at home in people with early Parkinson’s disease using an instrumented timed up and go test. Parkinsonism Relat Disord. 2011;17:277–280
   PubMed Web of Science ®Google Scholar
• Schlachetzki JCM, Barth J, Marxreiter F, et al. Wearable sensors objectively measure gait parameters in Parkinson’s disease. PLoS One. 2017;12:e0183989
   PubMed Web of Science ®Google Scholar
• Pasluosta CF, Barth J, Gassner H, et al. Pull test estimation in Parkinson’s disease patients using wearable sensor technology. Conf Proc IEEE Eng Med Biol Soc. 2015;2015:3109–3112
   PubMedGoogle Scholar
• Cantiniaux S, Vaugoyeau M, Robert D, et al. Comparative analysis of gait and speech in Parkinson’s disease: hypokinetic or dysrhythmic disorders? J Neurol Neurosurg Psychiatry. 2010;81:177–184
   PubMed Web of Science ®Google Scholar
• Moore ST, Yungher DA, Morris TR, et al. Autonomous identification of freezing of gait in Parkinson’s disease from lower-body segmental accelerometry. J Neuroeng Rehabil. 2013;13:10–19
   PubMed Web of Science ®Google Scholar
• Doan JB, Whishaw IQ, Pellis SM, et al. Challenging context affects standing reach kinematics among Parkinson’s disease patients. Behav Brain Res. 2010;214:135–141
   PubMed Web of Science ®Google Scholar
• Ganesan M, Pal PK, Gupta A, et al. Dynamic posturography in evaluation of balance in patients of Parkinson’s disease with normal pull test: concept of a diagonal pull test. Parkinsonism Relat Disord. 2010;16:595–599
   PubMed Web of Science ®Google Scholar
• Mancini M, Zampieri C, Carlson-Kuhta P, et al. Anticipatory postural adjustments prior to step initiation are hypometric in untreated Parkinson’s disease: an accelerometer-based approach. Eur J Neurol. 2009;16:1028–1034
   PubMed Web of Science ®Google Scholar
• Mak MK, Wong EC, Hui-Chan CW Quantitative measurement of trunk rigidity in parkinsonian patients. J Neurol. 2007;254:202–209.
   PubMed Web of Science ®Google Scholar
• Bleuse S, Cassim F, Blatt JL, et al. Anticipatory postural adjustments associated with arm movement in Parkinson’s disease: a biomechanical analysis. J Neurol Neurosurg Psychiatry. 2008;79:881–887
   PubMed Web of Science ®Google Scholar
• Pham TT, Moore ST, Lewis SJG, et al. Freezing of gait detection in Parkinson’s disease: a subject-independent detector using anomaly scores. IEEE Trans Biomed Eng. 2017;64:2719–2728
   PubMed Web of Science ®Google Scholar
• Stack E, Ashburn A Dysfunctional turning in Parkinson’s disease. Disabil Rehabil. 2008;30:1222–1229
   PubMed Web of Science ®Google Scholar
• Kotschet K, Johnson W, McGregor S, et al. Daytime sleep in Parkinson’s disease measured by episodes of immobility. Parkinsonism Relat Disord. 2014;20:578–583
   PubMed Web of Science ®Google Scholar
• Rabelo AG, Neves LP, Aps P et al. Objective assessment of Bradykinesia estimated from the wrist extension in older adults and patients with Parkinson’s disease. Ann Biomed Eng. 2017;45:2614–2625
   PubMed Web of Science ®Google Scholar
• Summa S, Tosi J, Taffoni F, et al. Assessing bradykinesia in Parkinson’s disease using gyroscope signals. IEEE Int Conf Rehabil Robot. 2017;2017:1556–1561
   PubMedGoogle Scholar
• Jobbágy A, Harcos P, Karoly R, et al. Analysis of finger-tapping movement.J Neurosci Methods. 2005;141:29–39
   PubMed Web of Science ®Google Scholar
• Castiello U, Bennett KM, Bonfiglioli C, et al. The reach-to-grasp movement in Parkinson’s disease before and after dopaminergic medication. Neuropsychologia. 2000;38:46–59
   PubMed Web of Science ®Google Scholar
• Popovic MB, Dzoljic E, Kostic V A method to assess hand motor blocks in Parkinson’s disease with digitizing tablet. Tohoku J Exp Med. 2008;216:317–324
   PubMed Web of Science ®Google Scholar
• Heremans E, Nackaerts E, Broeder S, et al. Handwriting impairments in people with Parkinson’s disease and freezing of gait. Neurorehabil Neural Repair. 2016;30:911–919
   PubMed Web of Science ®Google Scholar
• Van Gilst MM, van Mierlo P, Bloem BR, et al. Quantitative motor performance and sleep benefit in Parkinson disease. Sleep. 2015;38:1567–1573
   PubMed Web of Science ®Google Scholar
• Svensson P, Henningson C, Karlsson S Speech motor control in Parkinson’s disease: a comparison between a clinical assessment protocol and a quantitative analysis of mandibular movements. Folia Phoniatr (Basel). 1993;45:157–164
   PubMed Web of Science ®Google Scholar
• Müller T, Harati A Diadochokinetic movements differ between patients with Parkinson’s disease and controls. J Neural Transm (Vienna). 2010;117:189–195
   PubMed Web of Science ®Google Scholar
• Ricciardi L, Bologna M, Morgante F, et al. Reduced facial expressiveness in Parkinson’s disease: a pure motor disorder? J Neurol Sci. 2015;358:125–130.
   PubMed Web of Science ®Google Scholar
• Bologna M, Berardelli I, Paparella G, et al. Altered kinematics of facial emotion expression and emotion recognition deficits are unrelated in Parkinson’s disease. Front Neurol. 2016;7:230
   PubMed Web of Science ®Google Scholar
• Cano-de-la-Cuerda R, Vela-Desojo L, Miangolarra-Page JC, et al. Isokinetic dynamometry as a technologic assessment tool for trunk rigidity in Parkinson’s disease patients. NeuroRehabilitation. 2014;35:493–501
   PubMed Web of Science ®Google Scholar
• Espay AJ, Beaton DE, Morgante F, et al. Impairments of speed and amplitude of movement in Parkinson’s disease: a pilot study. Mov Disord. 2009;24:1001–1008
   PubMed Web of Science ®Google Scholar
• Wenzelburger R, Raethjen J, Löffler K, et al. Kinetic tremor in a reach-to-grasp movement in Parkinson’s disease. Mov Disord. 2000;15:1084–1094
   PubMed Web of Science ®Google Scholar
• Vaillancourt DE, Newell KM The dynamics of resting and postural tremor in Parkinson’s disease. Clin Neurophysiol. 2000;111:2046–2056
   PubMed Web of Science ®Google Scholar
• Jeon H, Lee W, Park H, et al. Automatic Classification of Tremor Severity in Parkinson’s Disease Using a Wearable Device. Sensors (Basel). 2017;17. doi:10.3390/s17092067
   Web of Science ®Google Scholar
• Fraiwan L, Khnouf R, Mashagbeh AR Parkinson’s disease hand tremor detection system for mobile application. J Med Eng Technol. 2016;40:127–134
   PubMedGoogle Scholar
• Thanawattano C, Pongthornseri R, Anan C, et al. Temporal fluctuations of tremor signals from inertial sensor: a preliminary study in differentiating Parkinson’s disease from essential tremor. Biomed Eng Online. 2015;14:101
   PubMed Web of Science ®Google Scholar
• Thanawattano C, Anan C, Pongthornseri R, et al. Temporal fluctuation analysis of tremor signal in Parkinson’s disease and essential tremor subjects. Conf Proc IEEE Eng Med Biol Soc. 2015;2015:6054–6057
   PubMedGoogle Scholar
• Lin PC, Chen KH, Yang BS, et al. A digital assessment system for evaluating kinetic tremor in essential tremor and Parkinson’s disease. BMC Neurol. 2018;18:25
   PubMed Web of Science ®Google Scholar
• Zeuner KE, Shoge RO, Goldstein SR, et al. Accelerometry to distinguish psychogenic from essential or parkinsonian tremor. Neurology. 2003;61:548–550
   PubMed Web of Science ®Google Scholar
• Balachandar A, Fasano A Characterizing orthostatic tremor using a smartphone application. Tremor Other Hyperkinet Mov (N Y). 2017;7:488
   PubMed Web of Science ®Google Scholar
• Godino-Llorente JI, Shattuck-Hufnagel S, Choi JY, et al. Towards the identification of idiopathic Parkinson’s disease from the speech. new articulatory kinetic biomarkers. PLoS One. 2017 Dec
   PubMed Web of Science ®Google Scholar
• Bunton K Patterns of lung volume use during an extemporaneous speech task in persons with Parkinson disease. J Commun Disord. 2005;38:331–348
   PubMed Web of Science ®Google Scholar
• Fischer E, Goberman AM Voice onset time in Parkinson disease. J Commun Disord. 2010;43:21–34
   PubMed Web of Science ®Google Scholar
• Vaiciukynas E, Verikas A, Gelzinis A, et al. Detecting Parkinson’s disease from sustained phonation and speech signals. PLoS One. 2017;12:e0185613
   PubMed Web of Science ®Google Scholar
• Gauvin HS, Mertens J, Mariën P, et al. Verbal monitoring in Parkinson’s disease: a comparison between internal and external monitoring. PLoS One. 2017;12:e0182159
   PubMed Web of Science ®Google Scholar
• Rektorova I, Mekyska J, Janousova E, et al. Speech prosody impairment predicts cognitive decline in Parkinson’s disease. Parkinsonism Relat Disord. 2016;29:90–95
   PubMed Web of Science ®Google Scholar
• Arora S, Venkataraman V, Zhan A, et al. Detecting and monitoring the symptoms of Parkinson’s disease using smartphones: A pilot study. Parkinsonism Relat Disord. 2015;21:650–653
   PubMed Web of Science ®Google Scholar
• Perez-Lloret S, Rossi M, Nouzeilles MI, et al. Parkinson’s disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients. J Neurol. 2009;256:1480–1484
   PubMed Web of Science ®Google Scholar
• Norlinah MI, Afidah KN, Noradina AT, et al. Sleep disturbances in Malaysian patients with Parkinson’s disease using polysomnography and PDSS. Parkinsonism Relat Disord. 2009;15:670–674
   PubMed Web of Science ®Google Scholar
• Loo HV, Tan EK Case-control study of restless legs syndrome and quality of sleep in Parkinson’s disease. J Neurol Sci. 2008;266:145–149
   PubMed Web of Science ®Google Scholar
• Shpirer I, Miniovitz A, Klein C, et al. Excessive daytime sleepiness in patients with Parkinson’s disease: a polysomnography study. Mov Disord. 2006;21:1432–1438
   PubMed Web of Science ®Google Scholar
• Alatriste-Booth V, Rodríguez-Violante M, Camacho-Ordoñez A, et al. Prevalence and correlates of sleep disorders in Parkinson’s disease: a polysomnographic study. Arq Neuropsiquiatr. 2015;73:241–245
   PubMed Web of Science ®Google Scholar
• Diederich NJ, Vaillant M, Leischen M, et al. Sleep apnea syndrome in Parkinson’s disease. A case-control study in 49 patients. Mov Disord. 2005;20:1413–1438
   PubMedGoogle Scholar
• Gagnon JF, Bédard MA, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology. 2002;59:585–589
   PubMed Web of Science ®Google Scholar
• Gagnon JF, Fantini ML, Bédard MA, et al. Association between waking EEG slowing and REM sleepbehavior disorder in PD without dementia. Neurology. 2004;62:401–406.
   PubMed Web of Science ®Google Scholar
• Valli K, Frauscher B, Peltomaa T et al. Dreaming furiously? A sleep laboratory study on the dream content of people with Parkinson’s disease and with or without rapid eye movement sleep behavior disorder. Sleep Med. 2015;16:419–427
   PubMed Web of Science ®Google Scholar
• Louter M, Arends JB, Bloem BR, et al. Actigraphy as a diagnostic aid for REM sleep behavior disorder in Parkinson’s disease. BMC Neurol. 2014;14:76
   PubMed Web of Science ®Google Scholar
• Comella CL, Tanner CM, Ristanovic RK Polysomnographic sleep measures in Parkinson’s disease patients with treatment-induced hallucinations. Ann Neurol. 1993;34:710–714
   PubMed Web of Science ®Google Scholar
• Schroeder LA, Rufra O, Sauvageot N, et al. Reduced rapid eye movement density in parkinson disease: a polysomnography-based case-control study. Sleep. 2016;39:213339.
   Web of Science ®Google Scholar
• Roth T, Rye DB, Borchert LD, et al. Assessment of sleepiness and unintended sleep in Parkinson’s disease patients taking dopamine agonists. Sleep Med. 2003;4:275–280
   PubMed Web of Science ®Google Scholar
• Möller JC, Stiasny K, Hargutt V, et al. Evaluation of sleep and driving performance in six patients with Parkinson’s disease reporting sudden onset of sleep under dopaminergic medication: a pilot study. Mov Disord. 2002;17:474–481
   PubMed Web of Science ®Google Scholar
• Möller JC, Unger M, Stiasny-Kolster K et al. Continuous sleep EEG monitoring in PD patients with and without sleepattacks. Parkinsonism Relat Disord. 2009;15:238–241
   PubMed Web of Science ®Google Scholar
• Dhawan V, Dhoat S, Williams AJ, et al. The range and nature of sleep dysfunction in untreated Parkinson’s disease (PD). A comparative controlled clinical study using the Parkinson’s disease sleep scale and selective polysomnography. J Neurol Sci. 2006;248:158–162
   PubMed Web of Science ®Google Scholar
• Vaughan CP, Juncos JL, Trotti LM, et al. Nocturia and overnight polysomnography in Parkinson disease. Neurourol Urodyn. 2013;32:1080–1085
   PubMed Web of Science ®Google Scholar
• Diederich NJ, Paolini V, Vaillant M Slow wave sleep and dopaminergic treatment in Parkinson’s disease: a polysomnographic study. Acta Neurol Scand. 2009;120:308–313
   PubMed Web of Science ®Google Scholar
• Zibetti M, Romagnolo A, Merola A, et al. A polysomnographic study in parkinsonian patients treated with intestinal levodopa infusion. J Neurol. 2017;264:1085–1090
   PubMed Web of Science ®Google Scholar
• Cicolin A, Lopiano L, Zibetti M, et al. Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients. Sleep Med. 2004;5:207–210
   PubMed Web of Science ®Google Scholar
• Young A, Home M, Churchward T, et al. Comparison of sleep disturbance in mild versus severe Parkinson’s disease. Sleep. 2002;25:573–577
   PubMed Web of Science ®Google Scholar
• Uemura Y, Nomura T, Inoue Y, et al. Validation of the Parkinson’s disease sleep scale in Japanese patients: a comparison study using the Pittsburgh sleep quality index, the epworth sleepiness scale and polysomnography. J Neurol Sci. 2009;287:36–40
   PubMed Web of Science ®Google Scholar
• Tanaka H, Koenig T, Pascual-Marqui RD, et al. Event-related potential and EEG measures in Parkinson’s disease without and with dementia. Dement Geriatr Cogn Disord. 2000;11:39–45
   PubMed Web of Science ®Google Scholar
• Fonseca LC, Tedrus GM, Letro GH, et al. Dementia, mild cognitive impairment and quantitative EEG in patients with Parkinson’s disease. Clin EEG Neurosci. 2009;40:168–172
   PubMed Web of Science ®Google Scholar
• Zimmermann R, Gschwandtner U, Hatz F, et al. Correlation of EEG slowing with cognitive domains in nondemented patients with Parkinson’s disease. Dement Geriatr Cogn Disord. 2015;39:207–214
   PubMed Web of Science ®Google Scholar
• Latreille V, Carrier J, Lafortune M, et al. Sleep spindles in Parkinson’s disease may predict the development of dementia. Neurobiol Aging. 2015;36:1083–1090
   PubMed Web of Science ®Google Scholar
• Markser A, Maier F, Lewis CJ, et al. Deep brain stimulation and cognitive decline in Parkinson’s disease: the predictive value of electroencephalography. J Neurol. 2015;262:2275–2284
   PubMed Web of Science ®Google Scholar
• Latreille V, Carrier J, Gaudet-Fex B, et al. Electroencephalographic prodromal markers of dementia across conscious states in Parkinson’s disease. Brain. 2016;139:1189–1199
   PubMed Web of Science ®Google Scholar
• Matsui H, Nishinaka K, Oda M, et al. Auditory event-related potentials in Parkinson’s disease: prominent correlation with attention. Parkinsonism Relat Disord. 2007;13:394–398
   PubMed Web of Science ®Google Scholar
• Katsarou Z, Bostantjopoulou S, Kimiskidis V, et al. Auditory event-related potentials in Parkinson’s disease in relation to cognitive ability. Percept Mot Skills. 2004;98:1441–1448
   PubMed Web of Science ®Google Scholar
• Bodis-Wollner I, Borod JC, Cicero B, et al. Modality dependent changes in event-related potentials correlate with specific cognitive functions in nondemented patients with Parkinson’s disease. J Neural Transm Park Dis Dement Sect. 1995;9:197–209
   PubMedGoogle Scholar
• Hawkes CH, Shephard BC, Daniel SE Olfactory dysfunction in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1997;62:436–446
   PubMed Web of Science ®Google Scholar
• Peppe A, Stanzione P, Pierelli F, et al. Visual alterations in de novo Parkinson’s disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials. Neurology. 1995;45:1144–1148
   PubMed Web of Science ®Google Scholar
• Pekkonen E, Jousmäki V, Reinikainen K, et al. Automatic auditory discrimination is impaired in Parkinson’s disease. Electroencephalogr Clin Neurophysiol. 1995;95:47–52
   PubMedGoogle Scholar
• Green J, Woodard JL, Sirockman BE, et al. Event-related potential P3 change in mild Parkinson’s disease. Mov Disord. 1996;11:32–42
   PubMed Web of Science ®Google Scholar
• Okuda B, Tachibana H, Kawabata K, et al. Visual evoked potentials (VEPs) in Parkinson’s disease: correlation of pattern VEPs abnormality with dementia. Alzheimer Dis Assoc Disord. 1995 Summer;9:68–72
   PubMed Web of Science ®Google Scholar
• Vieregge P, Verleger R, Wascher E, et al. Auditory selective attention is impaired in Parkinson’s disease–event-related evidence from EEG potentials. Brain Res Cogn Brain Res. 1994;2:117–129
   PubMedGoogle Scholar
• Nojszewska M, Pilczuk B, Zakrzewska-Pniewska B, et al. The auditory system involvement in Parkinson disease: electrophysiological and neuropsychological correlations. J Clin Neurophysiol. 2009;26:430–437
   PubMed Web of Science ®Google Scholar
• Kim GW, Sohn YH, Huh K, et al. Relationship between the auditory P300 and the procedural memory function in drug-naive patients with Parkinson’s disease. Yonsei Med J. 1995;36:367–371
   PubMedGoogle Scholar
• Sagliocco L, Bandini F, Pierantozzi M, et al. Electrophysiological evidence for visuocognitive dysfunction in younger non Caucasian patients with Parkinson’s disease. J Neural Transm (Vienna). 1997; 104 (4–5): 427–439
   PubMed Web of Science ®Google Scholar
• Antal A, Dibó G, Kéri S, et al. P300 component of visual event-related potentials distinguishes patients with idiopathic parkinson’s disease from patients with essential tremor. J Neural Transm (Vienna). 2000;107:787–797
   PubMed Web of Science ®Google Scholar
• Büttner T, Kuhn W, Müller T, et al. Chromatic and achromatic visual evoked potentials in Parkinson’s disease. Electroencephalogr Clin Neurophysiol. 1996;100:443–447
   PubMedGoogle Scholar
• Filipović SR, Sternić N, Svetel M, et al. Bereitschaftspotential in depressed and non-depressed patients with Parkinson’s disease. Mov Disord. 2001;16:294–300
   PubMed Web of Science ®Google Scholar
• Low PA, Tomalia VA, Park KJ Autonomic function tests: some clinical applications. J Clin Neurol. 2013;9:1–8
   PubMed Web of Science ®Google Scholar
• Oka H, Mochio S, Yoshioka M, et al. Evaluation of baroreflex sensitivity by the sequence method using blood pressure oscillations and R-R interval changes during deep respiration. Eur Neurol. 2003;50:230–243
   PubMed Web of Science ®Google Scholar
• Oka H, Mochio S, Sato H, et al. Prolongation of QTc interval in patients with Parkinson’s disease. Eur Neurol. 1997;37:186–189
   PubMed Web of Science ®Google Scholar
• Mastrocola C, Vanacore N, Giovani A et al. Twenty-four-hour heart rate variability to assess autonomic function in Parkinson’s disease. Acta Neurol Scand. 1999;99:245–247
   PubMed Web of Science ®Google Scholar
• Haapaniemi TH, Pursiainen V, Korpelainen JT, et al. Ambulatory ECG and analysis of heart rate variability in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2001;70:305–310
   PubMed Web of Science ®Google Scholar
• Tanaka R, Shimo Y, Yamashiro K, et al. Association between abnormal nocturnal blood pressure profile and dementia in Parkinson’s disease. Parkinsonism Relat Disord. 2018;46:24–29
   PubMed Web of Science ®Google Scholar
• Pavy-LeTraon A, Brefel-Courbon C, Dupouy J, et al. Combined cardiovascular and sweating autonomic testing to differentiate multiple system atrophy from Parkinson’s disease. Neurophysiol Clin. 2018;48:103–110
   PubMed Web of Science ®Google Scholar
• Baschieri F, Calandra-Buonaura G, Doria A, et al. Cardiovascular autonomic testing performed with a new integrated instrumental approach is useful in differentiating MSA-P from PD at an early stage. Parkinsonism Relat Disord. 2015;21:477–482
   PubMed Web of Science ®Google Scholar
• De Pablo-Fernandez E, Tur C, Revesz T, et al. Association of autonomic dysfunction with disease progression and survival in Parkinson disease. JAMA Neurol. 2017;74:970–976
   PubMed Web of Science ®Google Scholar
• Merola A, Romagnolo A, Comi C et al. Prevalence and burden of dysautonomia inadvanced Parkinson’s disease. Mov Disord. 2017;32:796–797
   PubMed Web of Science ®Google Scholar
• Artusi CA, Mishra M, Latimer P, et al. Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases. Parkinsonism Relat Disord. 2018;46:S53–S56
   PubMed Web of Science ®Google Scholar
• Onorati F, Regalia G, Caborni C, et al. Multicenter clinical assessment of improved wearable multimodal convulsive seizure detectors. Epilepsia. 2017;58:1870–1879
   PubMed Web of Science ®Google Scholar
• Ryvlin P, Ciumas C, Wisniewski I, et al. Wearable devices for sudden unexpected death in epilepsy prevention. Epilepsia. 2018;59 Suppl 1:61–66
   PubMedGoogle Scholar
• Ellis T, Cavanaugh JT, Earhart GM, et al. Which measures of physical function and motor impairment best predict quality of life in Parkinson’s disease? Parkinsonism Relat Disord. 2011;17:693–697
   PubMed Web of Science ®Google Scholar
• Sánchez-Ortuño MM, Edinger JD, Means MK, et al. Home is where sleep is: an ecological approach to test the validity of actigraphy for the assessment of insomnia. J Clin Sleep Med. 2010;6:21–29
   PubMed Web of Science ®Google Scholar
• Milazzo V, Di Stefano C, Vallelonga F, et al. Reverse blood pressuredipping as marker of dysautonomia in Parkinson disease. Parkinsonism RelatDisord. 2018. doi:10.1016/j.parkreldis.2018.06.032
   PubMedGoogle Scholar
• Merola A, Sawyer RP, Artusi CA, et al. Orthostatic hypotension in Parkinson disease: impact on health care utilization. Parkinsonism Relat Disord. 2018;47:45–49
   PubMed Web of Science ®Google Scholar
• Merola A, Romagnolo A, Rosso M, et al. Orthostatic hypotension in Parkinson’s disease: does it matter if asymptomatic? Parkinsonism Relat Disord. 2016 Dec;33:65–71
   PubMed Web of Science ®Google Scholar
• Espay AJ, Bonato P, Nahab FB, et al. Movement disorders society task force on technology. Technology in Parkinson’s disease: challenges and opportunities. Mov Disord. 2016;31:1272–1282
   PubMed Web of Science ®Google Scholar